Master Thesis Project: Stability Study for AAV Viral Vectors
Cytiva Sweden ABUppsala
- Anställning
- Heltid
- Publicerad
- 8 okt. 2026
Få ett CV och ett brev skrivna för det här jobbet
Ladda upp ditt CV. Jobbjagaren hittar det i din erfarenhet som jobbet frågar efter och skriver ett CV och ett personligt brev utifrån det. Det som saknas läggs inte till.
Få hjälp att söka jobbet4 ansökningar med CV och brev ingår gratis. Inget betalkort.
Visa originalannonsOm tjänsten
Bring more to life
Are you ready to accelerate your potential and make a real difference within life sciences, diagnostics and biotechnology?
At Cytiva, one of Danaher’s 15+ operating companies, our work saves lives—and we’re all united by a shared commitment to innovate for tangible impact.
You’ll thrive in a culture of belonging where you and your unique viewpoint matter. And by harnessing Danaher’s system of continuous improvement, you help turn ideas into impact – innovating at the speed of life
Working at Cytiva means being at the forefront of providing new solutions to transform human health. Our incredible customers undertake life-saving activities ranging from fundamental biological research to developing innovative vaccines, new medicines, and cell and gene therapies.
At Cytiva you will be able to continuously improve yourself and us – working on challenges that truly matter with people that care for each other, our customers, and their patients. Take your next step to an altogether life-changing career.
Learn about the Danaher Business System which makes everything possible.
What You'll Do:
The aim of this master thesis is to investigate the stability of adeno-associated virus (AAV) viral vectors with regards to their capsid and genome integrity under different storage conditions. Stability will be assessed using a range of orthogonal methods. The team are actively developing purification solutions for AAV, plasmids, and other viral vector entities used in both research and manufacturing. These vectors serve as delivery vehicles for DNA in cell and gene therapy applications. Our goal is to support customers by providing purification products that enable the production of high-purity viral vectors suitable for use as final drug substances. To ensure product quality, we utilize a comprehensive toolbox of analytical methods to assess parameters such as purity, concentration, and impurities. Accurate determination of AAV concentration during the purification process is critical. This thesis project will involve hands-on work of generating viral vector material in a start to finish process. Key is the use of analytical instruments and techniques for characterizing produced AAV material under variant storage conditions.
